| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |